What does Carevive do that my EHR doesn’t and how do I access the data?

In this video, John Elliott from Carevive sheds light on the questions surrounding Carevive’s unique offerings and how they differ from the EMR. Acknowledging the valid question of how Carevive stands apart, John explains that Carevive is complementary to the EMR, often fully embedded within it.

What sets Carevive apart is its ability to capture patient experience data, bridging the gaps between consults and infusion visits. While the EMR captures essential clinical data and documentation, it may not encompass the vital patient experience data. Carevive steps in to fill these gaps, providing discrete, trendable patient experience data, enabling proactive management and improved patient outcomes.

Accessing Carevive data can be seamless, as it’s often embedded within the EMR, ensuring an effortless user experience for clinicians. Dashboards offer real-time access to discreet ePROs data, empowering clinicians to take timely actions and improve patient care.

Moreover, from a process improvement perspective, Carevive data provides insights into symptom burden and quality of life for specific tumor types and treatments, guiding care services to focus on the highest severity symptoms.

Recent Episodes

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…